Abstract
Fragile X syndrome is the most common inherited form of mental retardation and is due to the silencing of FMR1 gene coding for the FMRP protein. FMRP is an RNA binding protein endowed with Nuclear Localization and Nuclear Export Signals and is associated with actively translating polysomes as part of mRNP complexes. During the past years, efforts from many laboratories to unravel the function of this protein, resulted in the identification of several proteins (mostly RNA-binding) and few hundred of mRNAs that are targeted by FMRP. The puzzle illustrating the FMRP role depicts a protein implicated in different steps of mRNA metabolism. However, its precise mechanism of action is not still understood and the specificity of its function is probably dependent on RNA and/or proteins that interact and associate with it.
Keywords: Fragile X syndrome, mental retardation, RNA-binding domains, RNA-binding proteins, mRNP-complexes, G-quartet, kissing-complex, Rac pathway
Current Genomics
Title: Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function
Volume: 6 Issue: 7
Author(s): E. W. Khandjian, E. Bechara, L. Davidovic and B. Bardoni
Affiliation:
Keywords: Fragile X syndrome, mental retardation, RNA-binding domains, RNA-binding proteins, mRNP-complexes, G-quartet, kissing-complex, Rac pathway
Abstract: Fragile X syndrome is the most common inherited form of mental retardation and is due to the silencing of FMR1 gene coding for the FMRP protein. FMRP is an RNA binding protein endowed with Nuclear Localization and Nuclear Export Signals and is associated with actively translating polysomes as part of mRNP complexes. During the past years, efforts from many laboratories to unravel the function of this protein, resulted in the identification of several proteins (mostly RNA-binding) and few hundred of mRNAs that are targeted by FMRP. The puzzle illustrating the FMRP role depicts a protein implicated in different steps of mRNA metabolism. However, its precise mechanism of action is not still understood and the specificity of its function is probably dependent on RNA and/or proteins that interact and associate with it.
Export Options
About this article
Cite this article as:
Khandjian W. E., Bechara E., Davidovic L. and Bardoni B., Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function, Current Genomics 2005; 6 (7) . https://dx.doi.org/10.2174/138920205775067701
DOI https://dx.doi.org/10.2174/138920205775067701 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microendophenotypes of Psychiatric Disorders: Phenotypes of Psychiatric Disorders at the Level of Molecular Dynamics, Synapses, Neurons, and Neural Circuits
Current Molecular Medicine The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH
Current Drug Targets Astrocyte-Neuron Interaction at Tripartite Synapses
Current Drug Targets Preface
Current Neuropharmacology Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
Protein & Peptide Letters Use of Bromine-76 and Iodine-123 Radiohalogenated Tracers in the Drug Development Process
Current Pharmaceutical Design Neuronal Excitability in Epileptogenic Zones Regulated by the Wnt/ Β-Catenin Pathway
CNS & Neurological Disorders - Drug Targets The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies
Medicinal Chemistry New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity
Mini-Reviews in Medicinal Chemistry Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
Current Drug Metabolism ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Endocrine Abnormalities Induced by Antiepileptic Drugs
Current Pediatric Reviews Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease
Current Pharmaceutical Design Synthesis and Biological Evaluation of New 4-Thiazolidinone Derivatives as Carbonic Anhydrase Inhibitors
Letters in Organic Chemistry Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry
Current Medicinal Chemistry Flavonoids as Natural Inhibitors of Jack Bean Urease Enzyme
Letters in Drug Design & Discovery Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets